Verapamil Hydrochloride Patent Expiration
Verapamil Hydrochloride is Used for treating cardiovascular disease through the administration of a calcium blocking vasodilator. It was first introduced by Mt Adams Technologies Llc
Verapamil Hydrochloride Patents
Given below is the list of patents protecting Verapamil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Covera-hs | US6096339 | Dosage form, process of making and using same |
Apr 04, 2017
(Expired) | Pfizer |
Verapamil Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Verapamil Hydrochloride:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Verapamil Effect in Cystic Fibrosis-related Dysglycemia | Rhode Island Hospital | NA |
NOT YET RECRUITING
(Jul 1, 2026)
| PHASE2 |